A 41 year old lady presented to the Out-Patient-Clinic as a case for screening for primary hepatocellular carcinoma (HCC) as she was hepatitis B antigen positive. Her history and physical examination were unremarkable. Blood investigations which included full blood count and liver function tests were all within normal limits. Alpha Feto protein was negative. Hepatic ultrasonography is done as part of the screening procedure, and it was noticed that the lady had a predominantly hyperechogenic mass with areas ofhypoechogenic reflections. The mass was 2 x 3 cm and located in segment 6 . Although the mass was not typical ofearly HCC, it was feared that it may be an HCC with fat content, so further assessment with CT, MRI and angiography was requested. The CT scan appearance was that of 2 x 3 cm single mass in segment 6 which was irregular and sharply demarcated, hypodense, partially enhanced in its Left upper corner after injecting contrast material and there was no calcification. The MRI showed a single mass in segment 6 which was of high signal character in both T I, T weighted images.
Angiography showed a hypervascular mass but unlike a typical haemangioma. The (See color plate III) 6 cases were diagnosed and 8 cases were autopsy findings. Detailed CT and ultrasonic appearances were described by Takayasu 9 in 1987 followed by first description ofthe MRI appearance. In 1988, Naito reviewed the world literature 7 and compared the renal and hepatic angiomyolipomas. The ultrastructure appearance was first described by Okada. In 1990, the only fine needle aspirations diagnosis 'was made pre-operatively18. Our report will be the first to our knowledge which showed the preoperative colour doppler and intra-operative ultrasound appearance ofthis tumour.
This benign rare hepatic tumour seems to be more common in females than males, male:female ratio is l:l.5; the mean affected age is (50.25 +_ 13.58) years. The minimum age was 30 years and the maximum is 76 years and it seems to affect females in a younger age group than males. There is no ethnic group predominance and unlike angiomyolipomas ofthe kidneys which is associated with tubular sclerosis 7 hepatic angiomyolipomas are not associated with any disease or even specific symptoms, so it is difficult to determine a high risk group for screening. (7.1%) . The appearance is that ofa hypodense hepatic mass but unlike metastasis which are usually multiple, irregular and contain calcification, angiomyolipomas contain no calcification and are sharply demarcated, injecting contrast medium to perform CT angiography can differentiate it from an haemangioma; angiomyolipoma partially enhance after infusion of contrast medium because ofthe fat content. Angiomyolipomas appear as a low attenuation mass but not uniform as in cases of hepatic lipomas. The most important differential diagnosis ofangiomyolipoma on a CT scan is lipoma, myolipoma and hepatocellular carcinoma with fatty metamorphosis9-22. In the latter case, the fat distribution is rather inhomogeneous and the non-fatty areas pick up the contrast quickly in the early phase ofthe CT angiography. The MRI appearance is that of high signal well defined mass in both T1-T2 weighted images.
Angiography was done in 7 cases (25%) 6,9,10,12,16,17. It shows the tumour as a hypervascular mass which is unlike an haemangioma. The radioisotopic appearance is that of positive uptake ofTC 99 hyphate, which is identical to focal nodular hyperplasia6.
The diagnostic method ofchoice is CT Scan. But it must be remembered that hepatocellular carcinoma can contain fat, so needle biopsy may be useful particularly ifit is positive for malignancy.
The preoperative colour doppler (Fig. 2) is like the ultrasound appearance but vascular sinuses can be demonstrated in the tumour prephery.
By intraoperative ultrasound (Fig. 3) . The mass appears as a hyperechogenic, well defined mass, it lacks the characteristics ofhepatocellular carcinoma; it is not as dense as on haemangioma, and there is no calcification. The mass has the same appearance in all sections of the scan unlike a hepatocellular carcinoma of the same size. The natural history of the tumour looks like as it is benign, because mitosis or dysplasia are not seen, however, premalignancy cannot be excluded or confirmed.
What to do when one is found? the most difficult question to be answered is whether it is angiomyolipoma or hepatoma with fat metamorphosis, probably resection is the safest approach but if hepatoma can be excluded by fine needle biopsy or by the radiologic appearance follow-up can be recommended.
INVITED COMMENTARY
Hepatic Angiomyolipoma is a rare benign mesenchymal tumour of the liver, first described by Ishak 
